J&J's Cypher Beats Medtronic Endeavor Stent In SORT-OUT III: Does It Matter?
This article was originally published in The Pink Sheet Daily
Executive Summary
Medtronic directly disputed the validity of the Cypher results, but at least one interventional cardiologist publicly urged a halt in use of Endeavor based on the data. Several other physicians at the ACC meeting, though, said the study should not have much of an impact on clinical practice in the context of all available data.